ChromaCode Initiates Strategic Shift to Oncology With New...

ChromaCode Initiates Strategic Shift to Oncology With New Leadership, Digital PCR Lung Cancer Test

Date

July 28, 2023

GenomeWeb:

NEW YORK – ChromaCode has begun to apply its qPCR multiplexing technology to digital PCR…

View full article

More Articles Here

ChromaCode and Protean BioDiagnostics Establish Strategic Partnership to Introduce a HDPCR-based NSCLC Assay in the U.S.

August 10, 2023

ChromaCode Announces Commercial Availability of HDPCR-based Non-Small-Cell Lung Cancer Assay

July 11, 2023

ChromaCode Announces Partnership with MedGenome to Bring HDPCR-based Diagnostics to India and the Middle East

April 27, 2023